Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Total 13F shares
-
13,805,464
-
Share change
-
+286,629
-
Total reported value
-
$538,109,000
-
Price per share
-
$39.05
-
Number of holders
-
41
-
Value change
-
+$10,183,214
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q2 2021
As of 30 Jun 2021,
Immunocore Holdings plc - Ordinary shares (IMCR) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,805,464 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Rock Springs Capital Management LP, RTW INVESTMENTS, LP, FMR LLC, BlackRock Inc., GENERAL ATLANTIC, L.P., Avidity Partners Management LP, Bain Capital Public Equity Management II, LLC, PERCEPTIVE ADVISORS LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.